Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Ishita, Sen"'
Autor:
Dharmender Malik, Vineet Pant, Ishita Sen, Parul Thakral, Subha Shankar Das, Virupakshappa CB
Publikováno v:
Diagnostics, Vol 13, Iss 13, p 2221 (2023)
Tumour sampling is indispensable to diagnostic and therapeutic decision making. Thus, 18F-FDG PET/CT has the potential to accurately discriminate between viable and non-viable tissues due to its ability to characterise the metabolism of visible tissu
Externí odkaz:
https://doaj.org/article/a53148a1b8f04a6fbe601b31facf752c
Autor:
Parul Thakral, Divya Manda, Subha Shankar Das, Pankaj Tandon, Virupakshappa CB, Dharmender Malik, Ishita Sen
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 38:8-14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::243d937bc743dbe204ada5ef02b9b98e
https://doi.org/10.1089/cbr.2022.0029
https://doi.org/10.1089/cbr.2022.0029
Publikováno v:
Bengal Journal of Otolaryngology and Head Neck Surgery, Vol 28, Iss 2 (2020)
Introduction Second primary malignancy as squamous cell carcinoma of larynx is rare after squamous cell carcinoma of buccal mucosa. Case Report A 47 year old male patient presented with a painless, progressive ulcer of left buccal mucosa nea
Externí odkaz:
https://doaj.org/article/bb29696a5c1b45c79a4e7c60654e29b3
Autor:
Ishita Sen
Publikováno v:
The Review of Financial Studies. 36:2175-2223
Variable annuities, the largest liability of U.S. life insurers, are investment products containing long-dated minimum return guarantees. I show that guarantees with similar economic risks are treated differently by regulation and these differences i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df3a875ec321570b7ad7e04f30b8bdcd
https://doi.org/10.1093/rfs/hhac083
https://doi.org/10.1093/rfs/hhac083
Publikováno v:
Finance and Economics Discussion Series. 2022:1-93
Homeowners’ insurance, a $15 trillion market by coverage, provides households financial protection from climate losses. Insurance premiums (rates) are subject to significant regulations at a state level in the United States. Using novel data on fil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::534ab2336bace6b5e9b090002c7369c6
https://doi.org/10.17016/feds.2022.064
https://doi.org/10.17016/feds.2022.064
Autor:
CB, Dharmender Malik, Vineet Pant, Ishita Sen, Parul Thakral, Subha Shankar Das, Virupakshappa
Publikováno v:
Diagnostics; Volume 13; Issue 13; Pages: 2221
Tumour sampling is indispensable to diagnostic and therapeutic decision making. Thus, 18F-FDG PET/CT has the potential to accurately discriminate between viable and non-viable tissues due to its ability to characterise the metabolism of visible tissu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::ec47efe47af09625d5d3128abb4792ab
Autor:
Parul Thakral, Subha Shankar Das, Shweta Dhiman, Divya Manda, C.B. Virupakshappa, Dharmender Malik, Ishita Sen
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::486ca4f64a0a33ac14c32ad0a6764ff1
https://doi.org/10.1089/cbr.2022.0080
https://doi.org/10.1089/cbr.2022.0080
Autor:
Divya, Manda, Parul, Thakral, Ishita, Sen, Subha Shankar, Das, Virupakshappa, Cb, Dharmender, Malik
Publikováno v:
Clinical Nuclear Medicine.
Differentiating infection and sterile inflammation is the main clinical concern of clinicians as they are closely related to each other. Although 18 F-FDG PET/CT imaging is widely used, its main disadvantage is its lack of specificity to discriminate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6655f2d5b10d916ecac551c7d4f8ff66
https://doi.org/10.1097/rlu.0000000000004317
https://doi.org/10.1097/rlu.0000000000004317
Autor:
Vinod Raina, Parul Thakral, Vineet Pant, Priya Tiwari, Subha Shankar Das, Ishita Sen, Divya Manda
Publikováno v:
Annals of Nuclear Medicine. 35:794-810
225Ac-PSMA-617 therapy has shown good response in many recent studies. We report our experience of targeted alpha therapy with 225Ac-PSMA-617 in mCRPC patients who have failed therapy with taxanes. Thirty-eight patients with CRPC with progressive dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b51dc9af1cd5839ce2efb1a2a5030b99
https://doi.org/10.1007/s12149-021-01617-4
https://doi.org/10.1007/s12149-021-01617-4
Autor:
Parul, Thakral, Divya, Manda, Subha Shankar, Das, Pankaj, Tandon, Virupakshappa, Cb, Dharmender, Malik, Ishita, Sen
Publikováno v:
Cancer biotherapyradiopharmaceuticals.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c360f991cb87086a021d45c4dfb324ec
https://pubmed.ncbi.nlm.nih.gov/35763304
https://pubmed.ncbi.nlm.nih.gov/35763304